GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (OTCPK:TBGNF) » Definitions » Cyclically Adjusted PB Ratio

Oxurion NV (Oxurion NV) Cyclically Adjusted PB Ratio : (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Oxurion NV Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Oxurion NV Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Oxurion NV's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Cyclically Adjusted PB Ratio Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.61 0.45 0.01 -

Oxurion NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 - 0.01 - -

Competitive Comparison of Oxurion NV's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Oxurion NV's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxurion NV's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oxurion NV's Cyclically Adjusted PB Ratio falls into.



Oxurion NV Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Oxurion NV's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Oxurion NV's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.035/128.2922*128.2922
=-0.035

Current CPI (Dec23) = 128.2922.

Oxurion NV Annual Data

Book Value per Share CPI Adj_Book
201412 7.106 99.086 9.201
201512 5.129 100.572 6.543
201612 3.209 102.614 4.012
201712 4.349 104.804 5.324
201812 3.116 107.252 3.727
201912 1.543 108.065 1.832
202012 0.800 108.511 0.946
202112 -0.031 114.705 -0.035
202212 -0.012 126.578 -0.012
202312 -0.035 128.292 -0.035

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oxurion NV  (OTCPK:TBGNF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Oxurion NV Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxurion NV (Oxurion NV) Business Description

Industry
Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.